Literature DB >> 9243743

Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

M F Cotch1, J G Pastorek, R P Nugent, S L Hillier, R S Gibbs, D H Martin, D A Eschenbach, R Edelman, J C Carey, J A Regan, M A Krohn, M A Klebanoff, A V Rao, G G Rhoads.   

Abstract

BACKGROUND: Several studies have suggested that pregnant women infected with Trichomonas vaginalis may be at increased risk of an adverse outcome. GOAL: To evaluate prospectively the association between T. vaginalis and risk of adverse pregnancy outcome in a large cohort of ethnically diverse women. STUDY
DESIGN: At University-affiliated hospitals and antepartum clinics in five United States cities, 13,816 women (5,241 black, 4,226 Hispanic, and 4,349 white women) were enrolled at mid-gestation, tested for T. vaginalis by culture, and followed up until delivery.
RESULTS: The prevalence of T. vaginalis infection at enrollment was 12.6%. Race-specific prevalence rates were 22.8% for black, 6.6% for Hispanic, and 6.1% for white women. After multivariate analysis, vaginal infection with T. vaginalis at mid-gestation was significantly associated with low birth weight (odds ratio 1.3; 95% confidence interval 1.1 to 1.5), preterm delivery (odds ratio 1.3; 95% confidence interval 1.1 to 1.4), and preterm delivery of a low birth weight infant (odds ratio 1.4; 95% confidence interval 1.1 to 1.6). The attributable risk of T. vaginalis infection associated with low birth weight weight in blacks was 11% compared with 1.6% in Hispanics and 1.5% in whites.
CONCLUSIONS: After considering other recognized risk factors including co-infections, pregnant women infected with T. vaginalis at mid-gestation were statistically significantly more likely to have a low birth weight infant, to deliver preterm, and to have a preterm low birth weight infant. Compared with whites and Hispanics, T. vaginalis infection accounts for a disproportionately larger share of the low birth weight rate in blacks.

Entities:  

Mesh:

Year:  1997        PMID: 9243743     DOI: 10.1097/00007435-199707000-00008

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  255 in total

1.  Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis.

Authors:  J R Schwebke; M F Venglarik; S C Morgan
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Viability of Trichomonas vaginalis in transport medium.

Authors:  A L Beverly; M Venglarik; B Cotton; J R Schwebke
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 3.  Recent advances: obstetrics.

Authors:  J M Roberts
Journal:  BMJ       Date:  2000-07-01

4.  Clinical Trials Report.

Authors:  Michael Augenbraun
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

5.  Timing of inoculation of the pouch makes no difference in increased detection of Trichomonas vaginalis by the InPouch TV method.

Authors:  Joan Barenfanger; Cheryl Drake; Chad Hanson
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females.

Authors:  R Crosby; R J DiClemente; G M Wingood; K Harrington; S L Davies; E W Hook; M K Oh
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

Review 7.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

8.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.

Authors:  F J Bowden; G P Garnett
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

9.  In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.

Authors:  Andrea L Crowell; Kolby A Sanders-Lewis; W Evan Secor
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 10.  Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.

Authors:  Jenell S Coleman; Charlotte A Gaydos; Frank Witter
Journal:  Obstet Gynecol Surv       Date:  2013-01       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.